Testing magnesium in dialysis fluid for people in OMAGOD study
Part of Blood & lymphatic, Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is for people already enrolled in the OMAGOD pilot study. It tests whether changing the amount of magnesium in a special dialysis fluid can reduce unwanted blood clotting and inflammation during dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be taking part in the OMAGOD pilot trial.
- You cannot join if you are not part of that pilot trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the type of fluid used during dialysis might affect calcium buildup in your blood vessels, which can be a problem for people on long-term dialysis. If you're on dialysis and stable, you may be able to join.
This trial studies whether giving magnesium helps people who are hospitalized with low magnesium levels. It may help correct low magnesium and improve how patients feel and recover.
This trial tests whether giving magnesium (MgSO4) in a personalized way can reduce complications for children having heart surgery with a heart-lung machine. It may help make recovery smoother.
This trial tests whether giving magnesium as part of a standard hospital protocol can lower the risk of irregular heartbeat and improve survival in patients admitted to the intensive care unit.
This study tests a change in dialysis fluid to help patients on hemodialysis better manage their mineral levels, which may reduce bone and heart problems.
This Phase 2 study tests MLD10 to help people with type 2 diabetes who have low magnesium levels. If you qualify, you may receive the study treatment to see if it improves magnesium-related health in a safe way.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.